Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Alzheimers Dement. 2019 Feb 15;15(4):506–514. doi: 10.1016/j.jalz.2018.12.008

Figure 5:

Figure 5:

The rate of change for each outcome for mutation carriers by disease stages and for the overall preclinical stage. Each vertical line includes three tickers for the mean and 95% confidence interval. If the vertical line covers the 0 on the y-axis, the rate of change is not significant. Only amyloid PET has significant rate of change over all three stages (thus the reference line is not shown).